BIC
PFE icon

Bridges Investment Counsel’s Pfizer PFE Stock Holding History

Bridges Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.32M Buy
38,326
+85
+0.2% +$2.9K 0.73% 41
2017
Q3 		$1.3M Sell
38,241
-54,134
-59% -$1.74M 0.72% 42
2017
Q2 		$2.94M Buy
92,375
+45,470
+97% +$1.43M 0.67% 48
2017
Q1 		$1.52M Sell
46,905
-35,752
-43% -$1.13M 0.44% 57
2016
Q4 		$2.55M Buy
82,657
+5,118
+7% +$156K 0.62% 53
2016
Q3 		$2.49M Buy
77,539
+4,269
+6% +$143K 0.53% 56
2016
Q2 		$2.45M Buy
73,270
+391
+0.5% +$12.5K 0.54% 57
2016
Q1 		$2.05M Buy
72,879
+43,135
+145% +$1.23M 0.44% 67
2015
Q4 		$946K Hold
29,744
– – 0.16% 84
2015
Q3 		$946K Sell
29,744
-47,716
-62% -$1.53M 0.16% 84
2015
Q2 		$2.46M Sell
77,460
-1,113
-1% -$36.3K 0.58% 55
2015
Q1 		$2.59M Buy
78,573
+37
+0% +$1.18K 0.59% 54
2014
Q4 		$2.32M Buy
78,536
+692
+0.9% +$19.8K 0.53% 56
2014
Q3 		$2.18M Sell
77,844
-1,526
-2% -$42.8K 0.5% 61
2014
Q2 		$2.23M Sell
79,370
-10,626
-12% -$303K 0.51% 60
2014
Q1 		$2.74M Sell
89,996
-2,214
-2% -$66K 0.64% 52
2013
Q4 		$2.68M Sell
92,210
-6,432
-7% -$187K 0.62% 53
2013
Q3 		$2.69M Sell
98,642
-1,520
-2% -$41.4K 0.67% 51
2013
Q2 		$2.66M Buy
+100,162
New +$2.77M 0.68% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bridges Investment Counsel's PFE Position: Q4 2017 in Review

Bridges Investment Counsel increased its Pfizer (PFE) stake by 0.22% in Q4 2017, buying an estimated $2.9K and bringing the position to 38,326 shares worth $1.32M. The position accounts for 0.73% of the portfolio, ranked #41.

Bridges Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $2.94M in Q2 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Bridges Investment Counsel held 38,326 shares of Pfizer worth $1.32M as of Q4 2017.
  • Bridges Investment Counsel bought 85 Pfizer shares in Q4 2017, an estimated $2.9K.
  • Pfizer made up 0.73% of Bridges Investment Counsel's portfolio in Q4 2017, its #41 holding.
  • Bridges Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's Pfizer position peaked at $2.94M in Q2 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.